In Frankel’s work relying on tyrosinase expressing-melanoma models, unsorted, CD4+ and CD8+ TCR-T cells exert cytotoxic activity against cognate target tumor cell line, both in vitro and in vivo. The gene discussed is CD4; the disease is neoplasm.